Cytokinetics, Incorporated · NASDAQ:CYTK

Lee Sung sold 23,906 Cytokinetics, Incorporated shares (Form 4)

Traded May 5, 2026 · Filed May 5, 2026

On May 5, 2026, Lee Sung (EVP, Chief Financial Officer) sold 23,906 Cytokinetics, Incorporated shares at US$76.87 for US$1.84M under a trading plan, leaving 63,221 shares. Filed May 5, 2026 (Form 4).

Sold
23,906 shares
Price
US$76.87
Value
US$1.84M
Holding after
63,221 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP, Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 5, 2026Common StockSale23,906US$76.8763,221Direct

Source

View original at SEC

Related